CD8A and neoplasm: Immunohistochemistry showed an increase in the number of CD3+/CD8+ tumor-infiltrating T lymphocytes in 13/17 patients, following MTE therapy (Figure 1), implying that MTE may improve prognosis through immunoregulation.